The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health

References

• Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. The Lancet. 2020;395(10219):200–24. doi:10.1016/S0140-6736(19)32989-7.
   Google Scholar
• Ounpuu S, Anand S, Yusuf S. The global burden of cardiovascular disease. Medsc Cardiol. 2002;4(1):S5-S13.
   Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442.
   Google Scholar
• Woting A, Blaut M. The intestinal microbiota in metabolic disease. Nutrients. 2016;8(4):202. doi:10.3390/nu8040202.
   Google Scholar
• Meyer KA, Bennett BJ. Diet and gut microbial function in metabolic and cardiovascular disease risk. Current Diabetes Reports. 2016;16(10):93. doi:10.1007/s11892-016-0791-x.
   Google Scholar
• Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT. Human genetics shape the gut microbiome. Cell. 2014;159(4):789–799. doi:10.1016/j.cell.2014.09.053.
   Google Scholar
• Fan Y, Pedersen O. 2020. Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology. 1–17.
   Google Scholar
• Zubcevic J, Baker A, Martyniuk CJ. Transcriptional networks in rodent models support a role for gut-brain communication in neurogenic hypertension: a review of the evidence. Physiol Genomics. 2017;49(7):327–338. doi:10.1152/physiolgenomics.00010.2017.
   Google Scholar
• Mashaqi S, Gozal D. Obstructive sleep apnea and systemic hypertension: gut dysbiosis as the mediator?. J Clin Sleep Med. 2019;15(10):1517–1527. doi:10.5664/jcsm.7990.
   Google Scholar
• Ko CY, Fan JM, Hu AK, Su HZ, Yang JH, Huang LM, Yan FR, Zhang HP, Zeng YM. Disruption of sleep architecture in prevotella enterotype of patients with obstructive sleep apnea-hypopnea syndrome. Brain Behav. 2019;9(5):e01287. doi:10.1002/brb3.1287.
   Google Scholar
• Fernández-Bello I, Monzón Manzano E, García Río F, Justo Sanz R, Cubillos-Zapata C, Casitas R, Sánchez B, Jaureguizar A, Acuña P, Alonso-Fernández A. 2020. Procoagulant state of sleep apnea depends on systemic inflammation and endothelial damage. Arch Bronconeumol.
   Google Scholar
• Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Reviews. 2010;90(3):859–904. doi:10.1152/physrev.00045.2009.
   Google Scholar
• Korecka A, Arulampalam V. The gut microbiome: scourge, sentinel or spectator?. J Oral Microbiol. 2012;4(1):9367. doi:10.3402/jom.v4i0.9367.
   Google Scholar
• Brown JM, Hazen SL. Microbial modulation of cardiovascular disease. Nat Reviews Microbiol. 2018;16(3):171–181. doi:10.1038/nrmicro.2017.149.
   Google Scholar
• Topping DL, Clifton PM. 2001. Short-chain fatty acids and human colonic function: roles leof resistant starch and nonstarch polysaccharides. Physiological reviews.
   Google Scholar
• Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. 2020. SCFA: mechanisms and functional importance in the gut. Proceedings of the Nutrition Society. 1–13.
   Google Scholar
• Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–2340. doi:10.1194/jlr.R036012.
   Google Scholar
• Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population. Front Microbiol. 2018;9:890. doi:10.3389/fmicb.2018.00890.
   Google Scholar
• Costantini L, Molinari R, Farinon B, Merendino N. Impact of omega-3 fatty acids on the gut microbiota. Int J Mol Sci. 2017;18(12):2645. doi:10.3390/ijms18122645.
   Google Scholar
• Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, De Los Reyes-gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185. doi:10.3389/fmicb.2016.00185.
   Google Scholar
• Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189–200. doi:10.1080/19490976.2015.1134082.
   Google Scholar
• Chambers ES, Preston T, Frost G, Morrison DJ. Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health. Curr Nutr Rep. 2018;7(4):198–206. doi:10.1007/s13668-018-0248-8.
   Google Scholar
• Wong JM. Gut microbiota and cardiometabolic outcomes: influence of dietary patterns and their associated components. The Am J Clin Nutr. 2014;100(suppl_1):369S–377S. doi:10.3945/ajcn.113.071639.
   Google Scholar
• Wan Y, Tang J, Li J, Li J, Yuan J, Wang F, Li D. Contribution of diet to gut microbiota and related host cardiometabolic health: diet-gut interaction in human health. Gut Microbes. 2020;11(3):603–609. doi:10.1080/19490976.2019.1697149.
   Google Scholar
• Hansen TH, Gøbel RJ, Hansen T, Pedersen O. The gut microbiome in cardio-metabolic health. Genome Med. 2015;7(1):1–16. doi:10.1186/s13073-015-0157-z.
   Google Scholar
• Savage DC. Microbial ecology of the gastrointestinal tract. Annu Review Microbiol. 1977;3(12):107–133. doi:10.1146/annurev.mi.31.100177.000543.
   Google Scholar
• Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Sci. 2001;292(5519):1115–1118. doi:10.1126/science.1058709.
   Google Scholar
• Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Sci. 2005;308:1635–1638.
   Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118(2):229–241. doi:10.1016/j.cell.2004.07.002.
   Google Scholar
• Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D. Population-level analysis of gut microbiome variation. Sci. 2016;352(6285):560–564. doi:10.1126/science.aad3503.
   Google Scholar
• Malla MA, Dubey A, Kumar A, Yadav S, Hashem A, Abd_Allah EF. Exploring the human microbiome: the potential future role of next-generation sequencing in disease diagnosis and treatment. Front Immunol. 2019;9:2868. doi:10.3389/fimmu.2018.02868.
   Google Scholar
• Montalto M, D’onofrio F, Gallo A, Cazzato A, Gasbarrini G. Intestinal microbiota and its functions. Digestive Liver Dis Suppl. 2009;3(2):30–34. doi:10.1016/S1594-5804(09)60016-4.
   Google Scholar
• Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, Mancini C, Cicerone C, Corazziari E, Pantanella F. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol. 2016;39:1–12.
   Google Scholar
• Schippa S, Conte MP. Dysbiotic events in gut microbiota: impact on human health. Nutr. 2014;6(12):5786–5805. doi:10.3390/nu6125786.
   Google Scholar
• Katsimichas T, Antonopoulos AS, Katsimichas A, Ohtani T, Sakata Y, Tousoulis D. The intestinal microbiota and cardiovascular disease. Cardiovasc Res. 2019;115(10):1471–1486. doi:10.1093/cvr/cvz135.
   Google Scholar
• Tang WW, Hazen SL. Microbiome, trimethylamine N-oxide, and cardiometabolic disease. Transl Res. 2017;179:108–115. doi:10.1016/j.trsl.2016.07.007.
   Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Human gut microbes associated with obesity. Nat. 2006;444(7122):1022–1023. doi:10.1038/4441022a.
   Google Scholar
• Tanti J-F, Ceppo F, Jager J, Berthou F. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol. 2013;3:181. doi:10.3389/fendo.2012.00181.
   Google Scholar
• Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat Reviews Immunol. 2014;14(1):9–23. doi:10.1038/nri3565.
   Google Scholar
• Curtiss LK, Tobias PS. Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res. 2009;50(Supplement):S340–S345. doi:10.1194/jlr.R800056-JLR200.
   Google Scholar
• Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111–124. doi:10.1016/j.cell.2016.02.011.
   Google Scholar
• Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595. doi:10.1016/j.cell.2015.11.055.
   Google Scholar
• Randrianarisoa E, Lehn-Stefan A, Wang X, Hoene M, Peter A, Heinzmann SS, Zhao X, Königsrainer I, Königsrainer A, Balletshofer B. Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans. Scientific Reports. 2016;6(1):1–9. doi:10.1038/srep26745.
   Google Scholar
• Dambrova M, Latkovskis G, Kuka J, Strele I, Konrade I, Grinberga S, Hartmane D, Pugovics O, Erglis A, Liepinsh E. Diabetes is associated with higher trimethylamine N-oxide plasma levels. Exp Clin Endocrinol Diabetes. 2016;124(04):251–256. doi:10.1055/s-0035-1569330.
   Google Scholar
• Schugar RC, Shih DM, Warrier M, Helsley RN, Burrows A, Ferguson D, Brown AL, Gromovsky AD, Heine M, Chatterjee A. The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue. Cell Reports. 2017;19(12):2451–2461. doi:10.1016/j.celrep.2017.05.077.
   Google Scholar
• Wahlström A, Sayin SI, Marschall H-U, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
   Google Scholar
• Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res. 2009;50(8):1509–1520. doi:10.1194/jlr.R900007-JLR200.
   Google Scholar
• Joyce SA, Gahan CG. Disease-associated changes in bile acid profiles and links to altered gut microbiota. Digestive Dis. 2017;35(3):169–177. doi:10.1159/000450907.
   Google Scholar
• Vítek L. Bile acids in the treatment of cardiometabolic diseases. Annals Hepatol. 2017;16(1):43–52. doi:10.5604/01.3001.0010.5496.
   Google Scholar
• Masella R, Santangelo C, D’archivio M, LiVolti G, Giovannini C, Galvano F. Protocatechuic acid and human disease prevention: biological activities and molecular mechanisms. Curr Med Chem. 2012;19(18):2901–2917. doi:10.2174/092986712800672102.
   Google Scholar
• Menni C, Hernandez MM, Vital M, Mohney RP, Spector TD, Valdes AM. Circulating levels of the anti-oxidant indoleproprionic acid are associated with higher gut microbiome diversity. Gut Microbes. 2019;16(10):688–695. doi:10.1080/19490976.2019.1586038.
   Google Scholar
• Al-Waiz M, Mikov M, Mitchell S, Smith R. The exogenous origin of trimethylamine in the mouse. Metab. 1992;41(2):135–136. doi:10.1016/0026-0495(92)90140-6.
   Google Scholar
• Zhu W, Buffa J, Wang Z, Warrier M, Schugar R, Shih D, Gupta N, Gregory J, Org E, Fu X. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine n‐oxide‐generating pathway, modulates platelet responsiveness and thrombosis risk. J Thrombosis and Haemostasis. 2018;16(9):1857–1872. doi:10.1111/jth.14234.
   Google Scholar
• Tang WW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut microbiota-dependent trimethylamine n-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circulation Res. 2015;116(3):448–455. doi:10.1161/CIRCRESAHA.116.305360.
   Google Scholar
• Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Review Med. 2015;66(1):343–359. doi:10.1146/annurev-med-060513-093205.
   Google Scholar
• Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta‐analysis of prospective studies. J Am Heart Association. 2017;6(7):e004947. doi:10.1161/JAHA.116.004947.
   Google Scholar
• Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y. Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Front Pharmacol. 2019;10. doi:10.3389/fphar.2019.00010.
   Google Scholar
• Keitel V, Kubitz R, Häussinger D. Endocrine and paracrine role of bile acids. WJG. 2008;14(37):5620. doi:10.3748/wjg.14.5620.
   Google Scholar
• Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends in Molecular Medicine. 2015;21(11):702–714. doi:10.1016/j.molmed.2015.09.001.
   Google Scholar
• Khurana S, Raufman JP, Pallone TL. Bile acids regulate cardiovascular function. Clinical and Translational Science. 2011;4(3):210–218. doi:10.1111/j.1752-8062.2011.00272.x.
   Google Scholar
• Aura A-M, Martin-Lopez P, O’Leary KA, Williamson G, Oksman-Caldentey K-M, Poutanen K, Santos-Buelga C. In vitro metabolism of anthocyanins by human gut microflora. European Journal of Nutrition. 2005;44(3):133–142. doi:10.1007/s00394-004-0502-2.
   Google Scholar
• Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551(7682):648–652. doi:10.1038/nature24661.
   Google Scholar
• De Mello VD, Paananen J, Lindström J, Lankinen MA, Shi L, Kuusisto J, Pihlajamäki J, Auriola S, Lehtonen M, Rolandsson O. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the finnish diabetes prevention study. Scientific Reports. 2017;7(1):46337. doi:10.1038/srep46337.
   Google Scholar
• Sanna S, Van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, Mujagic Z, Masclee AAM, Jonkers D, Oosting M. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600–605. doi:10.1038/s41588-019-0350-x.
   Google Scholar
• Medina-Vera I, Sanchez-Tapia M, Noriega-Lopez L, Granados-Portillo O, Guevara-Cruz M, Flores-López A, Avila-Nava A, Fernández M, Tovar A, Torres N. A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes. Diabetes & Metabolism. 2019;45(2):122–131. doi:10.1016/j.diabet.2018.09.004.
   Google Scholar
• Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut. 2018;67(11):1974–1983. doi:10.1136/gutjnl-2017-314968.
   Google Scholar
• Moss G, Smith P, Tavernier D. Glossary of class names of organic compounds and reactivity intermediates based on structure (IUPAC recommendations 1995). Pure and Applied Chemistry. 1995;67(8–9):1307–1375. doi:10.1351/pac199567081307.
   Google Scholar
• Layden BT, Angueira AR, Brodsky M, Durai V, Lowe JWL. Short chain fatty acids and their receptors: new metabolic targets. Translational Research. 2013;161(3):131–140. doi:10.1016/j.trsl.2012.10.007.
   Google Scholar
• Richards LB, Li M, Van Esch BC, Garssen J, Folkerts G. The effects of short-chain fatty acids on the cardiovascular system. PharmaNutrition. 2016;4:68–111.
   Google Scholar
• AsM H, Bjorck IM, Nyman EMG. Combinations of indigestible carbohydrates affect short-chain fatty acid formation in the hindgut of rats. The Journal of Nutrition. 2002;132(10):3098–3104. doi:10.1093/jn/131.10.3098.
   Google Scholar
• Bergman E. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiological Reviews. 1990;70(2):567–590. doi:10.1152/physrev.1990.70.2.567.
   Google Scholar
• Macfarlane J. 1995. Proteolysis and amino acid fermentation. Human colonic bacteria. 75–100.
   Google Scholar
• Darzi J, Frost GS, Robertson MD. Do SCFA have a role in appetite regulation?. Proceedings of the Nutrition Society. 2011;70(1):119–128. doi:10.1017/S0029665110004039.
   Google Scholar
• McNeil NI, Cummings J, James W. Short chain fatty acid absorption by the human large intestine. Gut. 1978;19(9):819–822. doi:10.1136/gut.19.9.819.
   Google Scholar
• Holtug K, Clausen M, Hove H, Christiansen J, Mortensen P. The colon in carbohydrate malabsorption: short-chain fatty acids, pH, and osmotic diarrhoea. Scandinavian Journal of Gastroenterology. 1992;27(7):545–552. doi:10.3109/00365529209000118.
   Google Scholar
• Cummings J, Pomare E, Branch W, Naylor C, Macfarlane G. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221–1227. doi:10.1136/gut.28.10.1221.
   Google Scholar
• Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society. 2003;62(1):67–72. doi:10.1079/PNS2002207.
   Google Scholar
• Macfarlane G, Gibson G, Cummings J. Comparison of fermentation reactions in different regions of the human colon. J Applied Bacteriology. 1992;72(1):57–64. doi:10.1111/j.1365-2672.1992.tb04882.x.
   Google Scholar
• Flint HJ, Duncan SH, Scott KP, Louis P. Links between diet, gut microbiota composition and gut metabolism. Proceedings of the Nutrition Society. 2015;74(1):13–22. doi:10.1017/S0029665114001463.
   Google Scholar
• Miller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Applied and Environmental Microbiology. 1996;62(5):1589–1592. doi:10.1128/AEM.62.5.1589-1592.1996.
   Google Scholar
• Rey FE, Faith JJ, Bain J, Muehlbauer MJ, Stevens RD, Newgard CB, Gordon JI. Dissecting the in vivo metabolic potential of two human gut acetogens. Journal of Biological Chemistry. 2010;285(29):22082–22090. doi:10.1074/jbc.M110.117713.
   Google Scholar
• Ragsdale SW, Pierce E. Acetogenesis and the wood–ljungdahl pathway of CO2 fixation. Biochim Biophys Acta Proteins Proteomics. 2008;1784:1873–1898.
   Google Scholar
• Reichardt N, Duncan SH, Young P, Belenguer A, Leitch CM, Scott KP, Flint HJ, Louis P. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. The ISME Journal. 2014;8(6):1323–1335. doi:10.1038/ismej.2014.14.
   Google Scholar
• Macy JM, Ljungdahl LG, Gottschalk G. Pathway of succinate and propionate formation in Bacteroides fragilis. Journal of Bacteriology. 1978;134(1):84–91. doi:10.1128/JB.134.1.84-91.1978.
   Google Scholar
• Macy JM, Probst I. The biology of gastrointestinal bacteroides. Annual Reviews in Microbiology. 1979;33(1):561–594. doi:10.1146/annurev.mi.33.100179.003021.
   Google Scholar
• Marchandin H, Teyssier C, Campos J, Jean-Pierre H, Roger F, Gay B, Carlier J-P, Jumas-Bilak E. Negativicoccus succinicivorans gen. Nov., sp. Nov., isolated from human clinical samples, emended description of the family veillonellaceae and description of negativicutes classis nov., selenomonadales ord. Nov. And acidaminococcaceae fam. Nov. in the bacterial phylum firmicutes. International Journal of Systematic and Evolutionary Microbiology. 2010;60(Pt 6):1271–1279. doi:10.1099/ijs.0.013102-0.
   Google Scholar
• Saxena R, Anand P, Saran S, Isar J, Agarwal L. Microbial production and applications of 1, 2-propanediol. Indian Journal of Microbiology. 2010;50(1):2–11. doi:10.1007/s12088-010-0017-x.
   Google Scholar
• Bobik TA, Havemann GD, Busch RJ, Williams DS, Aldrich HC. The propanediol utilization (PDU) operon of Salmonella enterica serovar typhimurium lt2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B12-dependent 1, 2-propanediol degradation. Journal of Bacteriology. 1999;181(19):5967–5975. doi:10.1128/JB.181.19.5967-5975.1999.
   Google Scholar
• Scott KP, Martin JC, Campbell G, Mayer C-D, Flint HJ. Whole-genome transcription profiling reveals genes up-regulated by growth on fucose in the human gut bacterium “Roseburia inulinivorans”. Journal of Bacteriology. 2006;188(12):4340–4349. doi:10.1128/JB.00137-06.
   Google Scholar
• Belzer C, Chia LW, Aalvink S, Chamlagain B, Piironen V, Knol J, De Vos WM. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. MBio. 2017;8(5). doi:10.1128/mBio.00770-17.
   Google Scholar
• Ze X, Le Mougen F, Duncan SH, Louis P, Flint HJ. Some are more equal than others: the role of “keystone” species in the degradation of recalcitrant substrates. Gut Microbes. 2013;4(3):236–240. doi:10.4161/gmic.23998.
   Google Scholar
• Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and Environmental Microbiology. 2004;70:5810–5817.
   Google Scholar
• Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters. 2009;294(1):1–8. doi:10.1111/j.1574-6968.2009.01514.x.
   Google Scholar
• Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA): acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Applied and Environmental Microbiology. 2002;68(10):5186–5190. doi:10.1128/AEM.68.10.5186-5190.2002.
   Google Scholar
• Louis P, Young P, Holtrop G, Flint HJ. Diversity of human colonic butyrate‐producing bacteria revealed by analysis of the butyryl‐CoA: acetate CoA‐transferase gene. Environmental Microbiology 2010;12(2):304–314. doi:10.1111/j.1462-2920.2009.02066.x.
   Google Scholar
• Pluznick JL. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors. Kidney International. 2016;90(6):1191–1198. doi:10.1016/j.kint.2016.06.033.
   Google Scholar
• Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan L-X, Rey F, Wang T. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences. 2013;110(11):4410–4415. doi:10.1073/pnas.1215927110.
   Google Scholar
• Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. 2019. The role of short-chain fatty acids in microbiota–gut–brain communication. Nature Reviews Gastroenterology & Hepatology. 1.
   Google Scholar
• Milligan G, Stoddart LA, Smith NJ. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. British Journal of Pharmacology. 2009;158(1):146–153. doi:10.1111/j.1476-5381.2009.00421.x.
   Google Scholar
• Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA. GPR109a is a G-protein–coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Research. 2009;69(7):2826–2832. doi:10.1158/0008-5472.CAN-08-4466.
   Google Scholar
• Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Molecular Cell. 2012;48(4):612–626. doi:10.1016/j.molcel.2012.08.033.
   Google Scholar
• Bose P, Dai Y, Grant S. Histone deacetylase inhibitor (hdaci) mechanisms of action: emerging insights. Pharmacol Ther. 2014;143:323–336.
   Google Scholar
• Alex S, Lange K, Amolo T, Grinstead JS, Haakonsson AK, Szalowska E, Koppen A, Mudde K, Haenen D, Roelofsen H. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ. Molecular and Cellular Biology. 2013;33(7):1303–1316. doi:10.1128/MCB.00858-12.
   Google Scholar
• Marinelli L, Martin-Gallausiaux C, Bourhis J-M, Béguet-Crespel F, Blottière HM, Lapaque N. Identification of the novel role of butyrate as ahr ligand in human intestinal epithelial cells. Scientific Reports. 2019;9(1):1–14. doi:10.1038/s41598-018-37019-2.
   Google Scholar
• Huart J, Leenders J, Taminiau B, Descy J, Saint-Remy A, Daube G, Krzesinski J-M, Melin P, De Tullio P, Jouret F. Gut microbiota and fecal levels of short-chain fatty acids differ upon 24-hour blood pressure levels in men. Hypertension. 2019;74(4):1005–1013. doi:10.1161/HYPERTENSIONAHA.118.12588.
   Google Scholar
• Pluznick JL. Microbial short-chain fatty acids and blood pressure regulation. Current Hypertension Reports. 2017;19(4):25. doi:10.1007/s11906-017-0722-5.
   Google Scholar
• Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiological Genomics. 2016;48(11):826–834. doi:10.1152/physiolgenomics.00089.2016.
   Google Scholar
• Marques FZ, Nelson E, Chu P-Y, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964–977. doi:10.1161/CIRCULATIONAHA.116.024545.
   Google Scholar
• Miyamoto J, Kasubuchi M, Nakajima A, Irie J, Itoh H, Kimura I. The role of short-chain fatty acid on blood pressure regulation. Current Opinion in Nephrology and Hypertension. 2016;25(5):379–383. doi:10.1097/MNH.0000000000000246.
   Google Scholar
• Sun D, Zhou T, Heianza Y, Li X, Fan M, Fonseca VA, Qi L. Type 2 diabetes and hypertension: a study on bidirectional causality. Circulation Research. 2019;124(6):930–937. doi:10.1161/CIRCRESAHA.118.314487.
   Google Scholar
• Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nature Reviews Endocrinology. 2015;11(10):577. doi:10.1038/nrendo.2015.128.
   Google Scholar
• Zadeh-Tahmasebi M, Duca FA, Rasmussen BA, Bauer PV, Côté CD, Filippi BM, Lam TK. Activation of short and long chain fatty acid sensing machinery in the ileum lowers glucose production in vivo. Journal of Biological Chemistry. 2016;291(16):8816–8824. doi:10.1074/jbc.M116.718460.
   Google Scholar
• Velazquez OC, Lederer HM, Rombeau JL. 1997. Butyrate and the colonocyte. Dietary fiber in health and disease. Springer. p. 123–134.
   Google Scholar
• Lupton JR. Microbial degradation products influence colon cancer risk: the butyrate controversy. The Journal of Nutrition. 2004;134(2):479–482. doi:10.1093/jn/134.2.479.
   Google Scholar
• Wang H, Shi P, Zuo L, Dong J, Zhao J, Liu Q, Zhu W. Dietary non-digestible polysaccharides ameliorate intestinal epithelial barrier dysfunction in IL-10 knockout mice. Journal of Crohn’s and Colitis. 2016;10(9):1076–1086. doi:10.1093/ecco-jcc/jjw065.
   Google Scholar
• Hung TV, Suzuki T. Dietary fermentable fibers attenuate chronic kidney disease in mice by protecting the intestinal barrier. The Journal of Nutrition. 2018;148(4):552–561. doi:10.1093/jn/nxy008.
   Google Scholar
• Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host & Microbe. 2015;17(5):662–671. doi:10.1016/j.chom.2015.03.005.
   Google Scholar
• Munford RS. Endotoxemia—menace, marker, or mistake?. Journal of Leukocyte Biology. 2016;100(4):687–698. doi:10.1189/jlb.3RU0316-151R.
   Google Scholar
• Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R. 2015. Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. Mediators of inflammation. doi:10.1155/2015/378658.
   Google Scholar
• Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences. 2011;108(Supplement_1):4592–4598. doi:10.1073/pnas.1011383107.
   Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost F, Brummer RJ. The role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics. 2008;27(2):104–119. doi:10.1111/j.1365-2036.2007.03562.x.
   Google Scholar
• Gaudier E, Jarry A, Blottiere H, De Coppet P, Buisine M, Aubert J, Laboisse C, Cherbut C, Hoebler C. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointestinal Liver Physiol. 2004;287(6):G1168–G1174. doi:10.1152/ajpgi.00219.2004.
   Google Scholar
• Zhao Y, Chen F, Wu W, Sun M, Bilotta AJ, Yao S, Xiao Y, Huang X, Eaves-Pyles TD, Golovko G. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunology. 2018;11(3):752–762. doi:10.1038/mi.2017.118.
   Google Scholar
• Puddu A, Sanguineti R, Montecucco F, Viviani GL. 2014. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators of Inflammation.
   Google Scholar
• Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. American Journal of Physiology-Endocrinology and Metabolism. 2006;290(3):E550–E559. doi:10.1152/ajpendo.00326.2004.
   Google Scholar
• De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut and Liver. 2012;6(1):10. doi:10.5009/gnl.2012.6.1.10.
   Google Scholar
• Savage A, Adrian T, Carolan G, Chatterjee V, Bloom S. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 1987;28(2):166–170. doi:10.1136/gut.28.2.166.
   Google Scholar
• Naslund E, Bogefors J, Skogar S, Gryback P, Jacobsson H, Holst JJ, Hellstrom PM. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 1999;277(3):R910–R916. doi:10.1152/ajpregu.1999.277.3.R910.
   Google Scholar
• Larraufie P, Martin-Gallausiaux C, Lapaque N, Dore J, Gribble F, Reimann F, Blottiere H. SCFAs strongly stimulate pyy production in human enteroendocrine cells. Scientific Reports. 2018;8(1):1–9. doi:10.1038/s41598-017-18259-0.
   Google Scholar
• Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications. 2014;5(1):1–11. doi:10.1038/ncomms4611.
   Google Scholar
• Soliman M, Kimura K, Ahmed M, Yamaji D, Matsushita Y, Okamatsu-Ogura Y, Makondo K, Saito M. Inverse regulation of leptin mRNA expression by short-and long-chain fatty acids in cultured bovine adipocytes. Domestic Animal Endocrinology. 2007;33(4):400–409. doi:10.1016/j.domaniend.2006.08.005.
   Google Scholar
• Lee S, Hossner K. Coordinate regulation of ovine adipose tissue gene expression by propionate. Journal of Animal Science. 2002;80(11):2840–2849. doi:10.2527/2002.80112840x.
   Google Scholar
• Al-Lahham SH, Roelofsen H, Priebe M, Weening D, Dijkstra M, Hoek A, Rezaee F, Venema K, Vonk RJ. Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest. 2010;40(5):401–407. doi:10.1111/j.1365-2362.2010.02278.x.
   Google Scholar
• Pingitore A, Chambers ES, Hill T, Maldonado IR, Liu B, Bewick G, Morrison DJ, Preston T, Wallis GA, Tedford C. The diet‐derived short chain fatty acid propionate improves beta‐cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes, Obesity and Metabolism. 2017;19(2):257–265. doi:10.1111/dom.12811.
   Google Scholar
• Li Q, Chen H, Zhang M, Wu T, Liu R. Altered short chain fatty acid profiles induced by dietary fiber intervention regulate ampk levels and intestinal homeostasis. Food & Function. 2019;10(11):7174–7187. doi:10.1039/C9FO01465A.
   Google Scholar
• Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway. Archives of Biochemistry and Biophysics. 2019;672:108057. doi:10.1016/j.abb.2019.07.022.
   Google Scholar
• Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, MacDougall K, Preston T, Tedford C, Finlayson GS. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744–1754. doi:10.1136/gutjnl-2014-307913.
   Google Scholar
• Yang L, Lin H, Lin W, Xu X. Exercise ameliorates insulin resistance of type 2 diabetes through motivating short-chain fatty acid-mediated skeletal muscle cell autophagy. Biology. 2020;9(8):203. doi:10.3390/biology9080203.
   Google Scholar
• Sa A, Roelofsen H, Rezaee F, Weening D, Hoek A, Vonk R, Venema K. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. European Journal of Clinical Investigation. 2012;42(4):357–364. doi:10.1111/j.1365-2362.2011.02590.x.
   Google Scholar
• Li G, Yao W, Jiang H. Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. The Journal of Nutrition. 2014;144(12):1887–1895. doi:10.3945/jn.114.198531.
   Google Scholar
• Hong Y-H, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi K-C, Feng DD, Chen C, Lee H-G. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 2005;146(12):5092–5099. doi:10.1210/en.2005-0545.
   Google Scholar
• Zhao Y, Liu J, Hao W, Zhu H, Liang N, He Z, Ma KY, Chen Z-Y. Structure-specific effects of short-chain fatty acids on plasma cholesterol concentration in male Syrian hamsters. Journal of Agricultural and Food Chemistry. 2017;65(50):10984–10992. doi:10.1021/acs.jafc.7b04666.
   Google Scholar
• Nguyen TD, Prykhodko O, Hållenius FF, Nyman M. Monobutyrin reduces liver cholesterol and improves intestinal barrier function in rats fed high-fat diets. Nutrients. 2019;11(2):308. doi:10.3390/nu11020308.
   Google Scholar
• Demigné C, Morand C, Levrat M-A, Besson C, Moundras C, Rémésy C. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. British Journal of Nutrition. 1995;74(2):209–219. doi:10.1079/BJN19950124.
   Google Scholar
• Lührs H, Gerke T, Müller J, Melcher R, Schauber J, Boxberger F, Scheppach W, Menzel T. Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis. Scandinavian Journal of Gastroenterology. 2002;37(4):458–466. doi:10.1080/003655202317316105.
   Google Scholar
• Maeda T, Towatari M, Kosugi H, Saito H. Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood, the Journal of the American Society of Hematology. 2000;96:3847–3856.
   Google Scholar
• Glauben R, Siegmund B. Inhibition of histone deacetylases in inflammatory bowel diseases. Molecular Medicine. 2011;17(5–6):426–433. doi:10.2119/molmed.2011.00069.
   Google Scholar
• Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti T-D. The nlrp3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32(3):379–391. doi:10.1016/j.immuni.2010.03.003.
   Google Scholar
• Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, Maruya M, McKenzie CI, Hijikata A, Wong C. Metabolite-sensing receptors GPR43 and GPR109a facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nature Communications. 2015;6(1):6734. doi:10.1038/ncomms7734.
   Google Scholar
• Huang N, Katz JP, Martin DR, Wu GD. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine. 1997;9(1):27–36. doi:10.1006/cyto.1996.0132.
   Google Scholar
• Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K. T reg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature. 2013;500(7461):232–236. doi:10.1038/nature12331.
   Google Scholar
• Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Ødum N. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Scientific Reports. 2015;5(1):1–10. doi:10.1038/srep16148.
   Google Scholar
• Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417–1435. doi:10.3390/nu5041417.
   Google Scholar
• Cobo ER, Kissoon-Singh V, Moreau F, Holani R, Chadee K. MUC2 mucin and butyrate contribute to the synthesis of the antimicrobial peptide cathelicidin in response to entamoeba histolytica-and dextran sodium sulfate-induced colitis. Infection and Immunity. 2017;85(3). doi:10.1128/IAI.00905-16.
   Google Scholar
• Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL. Control of the innate epithelial antimicrobial response is cell‐type specific and dependent on relevant microenvironmental stimuli. Immunology. 2006;118(4):509–519. doi:10.1111/j.1365-2567.2006.02399.x.
   Google Scholar
• Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–450. doi:10.1038/nature12721.
   Google Scholar
• Li M, van Esch BC, Henricks PA, Folkerts G, Garssen J. 2018. The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide-or tumor necrosis factor α-stimulated endothelial cells via activation of GPR41/43 and inhibition of HDACs. Frontiers in pharmacology. 9:533.
   Google Scholar
• Bartolomaeus H, Balogh A, Yakoub M, Homann S, Markó L, Höges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139(11):1407–1421. doi:10.1161/CIRCULATIONAHA.118.036652.
   Google Scholar
• Kang C, Wang B, Kaliannan K, Wang X, Lang H, Hui S, Huang L, Zhang Y, Zhou M, Chen M. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. MBio. 2017;8(3):e00470-17.
   Google Scholar
• Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson G, Delzenne NM. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50(11):2374–2383. doi:10.1007/s00125-007-0791-0.
   Google Scholar
• Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65(3):426–436. doi:10.1136/gutjnl-2014-308778.
   Google Scholar
• Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nature Communications. 2013;4(1):1–12. doi:10.1038/ncomms2852.
   Google Scholar
• Lin HV, Frassetto A, Kowalik JEJ, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PloS One. 2012;7(4):e35240. doi:10.1371/journal.pone.0035240.
   Google Scholar
• Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509–1517. doi:10.2337/db08-1637.
   Google Scholar
• Sakakibara S, Yamauchi T, Oshima Y, Tsukamoto Y, Kadowaki T. Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic kk-a (y) mice. Biochemical and Biophysical Research Communications. 2006;344(2):597–604. doi:10.1016/j.bbrc.2006.03.176.
   Google Scholar
• Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A, Alipour S, Alamdari NM, Barati M, Ostadrahimi A. Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial. Hormone and Metabolic Research. 2017;49(11):886–891. doi:10.1055/s-0043-119089.
   Google Scholar
• Liu S-H, Chiu C-Y, Wang L-P, Chiang M-T. Omega-3 fatty acids-enriched fish oil activates AMPK/PGC-1α signaling and prevents obesity-related skeletal muscle wasting. Marine Drugs. 2019;17(6):380. doi:10.3390/md17060380.
   Google Scholar
• Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J. Primary prevention of cardiovascular disease with a mediterranean diet. New England Journal of Medicine. 2013;368(14):1279–1290. doi:10.1056/NEJMoa1200303.
   Google Scholar
• Djekic D, Shi L, Brolin H, Carlsson F, Särnqvist C, Savolainen O, Cao Y, Bäckhed F, Tremaroli V, Landberg R. Effects of a vegetarian diet on cardiometabolic risk factors, gut microbiota, and plasma metabolome in subjects with ischemic heart disease: a randomized, crossover study. Journal of the American Heart Association. 2020;9(18):e016518. doi:10.1161/JAHA.120.016518.
   Google Scholar
• Robertson RC, Oriach CS, Murphy K, Moloney GM, Cryan JF, Dinan TG, Ross RP, Stanton C. Deficiency of essential dietary n-3 PUFA disrupts the caecal microbiome and metabolome in mice. British Journal of Nutrition. 2017;118(11):959–970. doi:10.1017/S0007114517002999.
   Google Scholar
• Brüssow H, Parkinson SJ. You are what you eat. Nature Biotechnology. 2014;32(3):243–245. doi:10.1038/nbt.2845.
   Google Scholar
• Wu GD, Chen J, Hoffmann C, Bittinger K, Chen -Y-Y, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105–108. doi:10.1126/science.1208344.
   Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi:10.1038/nature12820.
   Google Scholar
• Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, Bäckhed F, Lusis AJ. Interactions between roseburia intestinalis and diet modulate atherogenesis in a murine model. Nature Microbiology. 2018;3(12):1461–1471. doi:10.1038/s41564-018-0272-x.
   Google Scholar
• Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359:1151–1156.
   Google Scholar
• Weitkunat K, Schumann S, Petzke KJ, Blaut M, Loh G, Klaus S. Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. The Journal of Nutritional Biochemistry. 2015;26(9):929–937. doi:10.1016/j.jnutbio.2015.03.010.
   Google Scholar
• Kim MS, Hwang SS, Park EJ, Bae JW. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environmental Microbiology Reports. 2013;5(5):765–775. doi:10.1111/1758-2229.12079.
   Google Scholar
• De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences. 2010;107(33):14691–14696. doi:10.1073/pnas.1005963107.
   Google Scholar
• Gutiérrez-Díaz I, Fernández-Navarro T, Sánchez B, Margolles A, González S. Mediterranean diet and faecal microbiota: a transversal study. Food & Function. 2016;7(5):2347–2356. doi:10.1039/C6FO00105J.
   Google Scholar
• Menni C, Zierer J, Pallister T, Jackson MA, Long T, Mohney RP, Steves CJ, Spector TD, Valdes AM. Omega-3 fatty acids correlate with gut microbiome diversity and production of n-carbamylglutamate in middle aged and elderly women. Scientific Reports. 2017;7(1):1–11. doi:10.1038/s41598-017-10382-2.
   Google Scholar
• Balfegó M, Canivell S, Hanzu FA, Sala-Vila A, Martínez-Medina M, Murillo S, Mur T, Ruano EG, Linares F, Porras N. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial. Lipids in Health and Disease. 2016;15(1):78. doi:10.1186/s12944-016-0245-0.
   Google Scholar
• Noriega BS, Sanchez-Gonzalez MA, Salyakina D, Coffman J. 2016. Understanding the impact of omega-3 rich diet on the gut microbiota. Case reports in medicine. doi:10.1155/2016/3089303.
   Google Scholar
• Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, Khlebnikov A, Van Hylckama Vlieg JE, Punit S, Glickman JN. 2010. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proceedings of the National Academy of Sciences. 107( 42):18132–18137.
   Google Scholar
• Veiga P, Pons N, Agrawal A, Oozeer R, Guyonnet D, Brazeilles R, Faurie J-M, Van Hylckama Vlieg JE, Houghton LA, Whorwell PJ. Changes of the human gut microbiome induced by a fermented milk product. Scientific Reports. 2015;4(1):6328. doi:10.1038/srep06328.
   Google Scholar
• Zhang H, Sun J, Liu X, Hong C, Zhu Y, Liu A, Li S, Guo H, Ren F. Lactobacillus paracasei subsp. paracasei lc01 positively modulates intestinal microflora in healthy young adults. Journal of Microbiology. 2013;51(6):777–782. doi:10.1007/s12275-013-3279-2.
   Google Scholar
• Jayachandran M, Chung SSM, Xu B. A critical review on diet-induced microbiota changes and cardiovascular diseases. Critical Reviews in Food Science and Nutrition. 2020;60(17):2914–2925. doi:10.1080/10408398.2019.1666792.
   Google Scholar
• Jones JM. Codex-aligned dietary fiber definitions help to bridge the ‘fiber gap’. Nutrition Journal. 2014;13(1):34. doi:10.1186/1475-2891-13-34.
   Google Scholar
• Slavin JL. Dietary fiber: classification, chemical analyses, and food sources. Journal of the American Dietetic Association. 1987;87:1164–1171.
   Google Scholar
• Dreher ML. Connection between fiber, colonic microbiota, and health across the human life cycle. Dietary Fiber in Health and Disease. Springer. 2018;67–93.
   Google Scholar
• Vijay A, Astbury S, Le Roy C, Spector TD, Valdes AM. The prebiotic effects of omega-3 fatty acid supplementation: a six-week randomised intervention trial. Gut Microbes. 2021;13(1):1–11. doi:10.1080/19490976.2020.1863133.
   Google Scholar